Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2014 | Viamet Pharmaceuticals | $60.0M Series D | Adrian Howd, Woodford Investment Management | Hatteras Venture Partners, Astellas Venture Management, Intersouth Partners, Lilly Ventures, Lurie Investments, Novartis |